These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19668152)

  • 1. A blueprint for biotech's blues.
    Nat Biotechnol; 2009 Aug; 27(8):675. PubMed ID: 19668152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotech's perfect storm.
    Karberg S
    Cell; 2009 Aug; 138(3):413-5. PubMed ID: 19665960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal gazing: biotech's financial outlook: the biotech analyst's view.
    Schmidt E
    Nat Biotechnol; 2006 Mar; 24(3):261-2. PubMed ID: 16525376
    [No Abstract]   [Full Text] [Related]  

  • 4. Australian states compete for biotech primacy.
    Norrie C
    Nat Biotechnol; 2002 Aug; 20(8):760. PubMed ID: 12147988
    [No Abstract]   [Full Text] [Related]  

  • 5. Biotech's wonder ride.
    Rynecki D
    Fortune; 2000 Mar; 141(5):435-6. PubMed ID: 10788046
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotech's twentieth birthday blues.
    Miska D
    Nat Rev Drug Discov; 2003 Mar; 2(3):231-3. PubMed ID: 12612649
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotech's uncertain present.
    Lancet; 1996 Jun; 347(9014):1497. PubMed ID: 8684093
    [No Abstract]   [Full Text] [Related]  

  • 8. Biotech's billion dollar breakthrough.
    Stipp D
    Fortune; 2003 May; 147(10):96-8, 100, 103. PubMed ID: 12776500
    [No Abstract]   [Full Text] [Related]  

  • 9. Boosting biotech in Finland.
    Smaglik P
    Nature; 2004 Oct; 431(7011):1020-1. PubMed ID: 15496931
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotech's gender gap.
    Littlehales C
    Nat Biotechnol; 2005 Sep; 23(9):1041-2. PubMed ID: 16222766
    [No Abstract]   [Full Text] [Related]  

  • 11. Biotech's baby boom.
    Hodgson J
    Nat Biotechnol; 2019 May; 37(5):502-512. PubMed ID: 31053818
    [No Abstract]   [Full Text] [Related]  

  • 12. Biotech's wellspring: a survey of the health of the private sector.
    Huggett B
    Nat Biotechnol; 2012 May; 30(5):395-400. PubMed ID: 22565961
    [No Abstract]   [Full Text] [Related]  

  • 13. Biotech's wellspring: the health of private biotech in 2013.
    Huggett B
    Nat Biotechnol; 2014 May; 32(5):428-35. PubMed ID: 24811512
    [No Abstract]   [Full Text] [Related]  

  • 14. Big pharma swallows biotech's pride.
    Huggett B
    Nat Biotechnol; 2008 Sep; 26(9):955-6. PubMed ID: 18779785
    [No Abstract]   [Full Text] [Related]  

  • 15. Indian biotech's bumpy road.
    Basu P
    Nature; 2007 Nov; 450(7169):580-1. PubMed ID: 18087777
    [No Abstract]   [Full Text] [Related]  

  • 16. India's budget keeps dream of genomics hub alive.
    Padma TV
    Nature; 2016 Mar; 531(7592):16-7. PubMed ID: 26935674
    [No Abstract]   [Full Text] [Related]  

  • 17. Australian biotech suffers growing pains.
    O'Neill G
    Nat Biotechnol; 2005 Apr; 23(4):401-2. PubMed ID: 15815652
    [No Abstract]   [Full Text] [Related]  

  • 18. Surprise US election results may boost biotech.
    Fox JL
    Nat Biotechnol; 2002 Dec; 20(12):1176. PubMed ID: 12454655
    [No Abstract]   [Full Text] [Related]  

  • 19. Share slump brings biotech firms to government's door.
    Check E
    Nature; 2003 Jun; 423(6943):908. PubMed ID: 12827159
    [No Abstract]   [Full Text] [Related]  

  • 20. This means war.
    Nat Biotechnol; 2008 Sep; 26(9):954. PubMed ID: 18779784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.